Results 261 to 270 of about 1,550,800 (360)

Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer

open access: yesAdvanced Materials, Volume 37, Issue 35, September 4, 2025.
The artesunate nanoplatform selectively targets ECM CAF, functioning as a GTPase inhibitor through disruption of intracellular serine homeostasis. This metabolic intervention effectively suppresses MAPK cascade activity, which consequently inhibits PTT‐induced CAF to ECM CAF differentiation.
Dongdong Zheng   +19 more
wiley   +1 more source

The use of indocyanine green and technetium-99 for dual-tracer sentinel lymph node biopsy in breast cancer. [PDF]

open access: yesBreast Cancer Res Treat
Kolbow M   +7 more
europepmc   +1 more source

Predictors for sentinel lymph node mapping failure using indocyanine green injection in apparent early stages of endometrial cancer: A single‐center prospective study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 170, Issue 3, Page 1214-1224, September 2025.
Abstract Objective The current study aimed to analyze predictive factors of sentinel lymph node mapping failure in apparently early stages of endometrial cancer using intracervical indocyanine green injection. Methods A single‐center prospective study was conducted between June 2019 and August 2023 at the Department of Gynecology and Obstetrics ...
Petra Bretová   +8 more
wiley   +1 more source

Application of Indocyanine Green Angiography for Perfusion Assessment of Buccal Myomucosal Flaps. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Ting J   +4 more
europepmc   +1 more source

Cancer of the cervix uteri: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 87-108, September 2025.
Abstract Since the publication of the 2021 FIGO Cancer Report, there has been further progress in the global effort to attain the WHO goal of cervical cancer elimination using a three‐pillar approach of vaccination, screening, and treatment. The HPV vaccination is now included in the national program of over 140 countries.
Neerja Bhatla   +3 more
wiley   +1 more source

Use of laser-assisted indocyanine green (ICG) fluorescent dye angiography in surgical excision of glomuvenous malformations. [PDF]

open access: yesCase Reports Plast Surg Hand Surg
Melley M   +7 more
europepmc   +1 more source

Cancer of the corpus uteri: A 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 60-77, September 2025.
Abstract Endometrial cancer comprises a heterogeneous group of neoplasms. Its incidence is increasing, as is mortality from endometrial cancer. This article updates many aspects surrounding endometrial cancer, covering histopathology, staging, surgical and non‐surgical management, follow‐up, and management of recurrent disease.
Martin Koskas   +6 more
wiley   +1 more source

Cancer of the vulva: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 36-47, September 2025.
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye   +3 more
wiley   +1 more source

Refining Prognosis and Treatment Strategies Beyond the Barcelona Clinic Liver Cancer Stage in Hepatocellular Carcinoma with Lung Metastases: A Multicenter Cohort Study

open access: yesMedComm, Volume 6, Issue 9, September 2025.
This multicenter cohort study revealed that lung metastasis worsens prognosis in hepatocellular carcinoma. However, selected patients with early‐stage intrahepatic tumors benefit from hepatectomy or RFA, achieving outcomes comparable to nonmetastatic cases. Combination therapy with TKIs and ICIs further improves survival.
Feng Xia   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy